CLINICAL_TRIALS
trial_result
· 2011-06-28
Clinical Trial Update: Efficacy and Safety of Aliskiren in Patients With Mild to Moderate Hypertension During Exercise [Phase 2]
Summary
Phase 2 trial results evaluate the efficacy and safety of aliskiren in patients with mild to moderate hypertension during exercise.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Novartis | Conditions: Hypertension | Phase 2 | Status: COMPLETED | Results posted: 2011-06-28